Compare

Trupanion/$TRUP

1D1W1M3M6MYTD1Y5YMAX

About Trupanion

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue majorly from subscription fees related to the company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions. Geographically, the company operates in United States, which derives maximum revenue; and Canada and Others.
Ticker
$TRUP
Sector
Finance
Primary listing
NASDAQ
Employees
1,121

Trupanion Metrics

BasicAdvanced
$1.3B
56.33
$0.53
1.45
-

What the Analysts think about Trupanion

Analyst ratings (Buy, Hold, Sell) for Trupanion stock.
Analyst projections of the future price of Trupanion stock.

Bulls say / Bears say

Subscription revenue rose 14% year on year in Q2, with subscription pets up 5% and retention at 98.37%. Net subscription pet additions grew 39% year on year, suggesting recent acquisition efforts are gaining traction. (Nasdaq, The Motley Fool)
The core subscription business is converting growth into stronger operating returns: adjusted operating income rose 24% and its margin widened to 15% from 13.8%. Q2 free cash flow also increased to $19.2 million from $12.0 million a year earlier. (The Motley Fool)
Trupanion is expanding its routes to customers through a new integration with veterinary practice software platform Digitail, bringing its claims and payment tools into clinic workflows. Management also said it plans to launch a new digital insurance offering in the first half of 2027, which could extend its reach to new customer groups. (Trupanion, The Motley Fool)
Total enrolled pets fell 2% year on year in Q2, despite growth in subscriptions, and Trupanion expects to end its Pets Best relationship after Q3 2028. The contract exit could weigh on the other business segment’s volume and revenue as those policies run off. (SEC)
Claims costs remain a risk to underwriting margins: Trupanion reported $2.4 million of unfavourable veterinary-invoice reserve development in the first half of 2026, driven by higher-than-expected claim frequency in older accident years. The company also says pricing changes can take time to secure regulatory approval and flow through policies, leaving margins exposed if costs rise quickly. (SEC)
Pet acquisition is becoming more expensive: average acquisition cost rose to $299 in Q2 from $276 a year earlier. Piper Sandler also flagged a contracting US puppy veterinary-visit funnel and an ageing pet cohort with costlier care, which could constrain new-customer growth and pressure margins. (The Motley Fool, Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 26 Oct 2026.

Trupanion Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Trupanion Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Trupanion

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.